Back

Questions & answers.

1 July 2021 (12:00 - 12:05)
Organised by:
Congress Presentation Part of: Management of Arrhythmias in Cardiac Dysfunction Patients: ESC Guidelines Update & New Approaches with Landiolol Pharmacotherapy Open Access Heart Failure 2021

4 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Video
Presentation thumbnail
Intravenous landiolol, a novel β (1)-adrenergic blocker for patients with cardiac dysfunction and atrial fibrillation.
Professor H. Puererfellner (Linz, AT)
Video
Presentation thumbnail
Questions and answers.
Presentation thumbnail
Management of Atrial Fibrillation in patients with cardiac dysfunction. The 2020 ESC Guidelines and the addition of Landiolol.
Professor Z. Fras (Ljubljana, SI)
Video

Access the full session

Session thumbnail
Management of Arrhythmias in Cardiac Dysfunction Patients: ESC Guidelines Update & New Approaches with Landiolol
Video

The Event

Event poster

Heart Failure 2021

1 July 2021 12:00 CET
You may be interested in
thumbnail
Congress Presentation
EAS Consensus on Lp(a) 2022- What to measure, in whom to measure, how to interpret and what to do - Q&A .
29 August 2022
thumbnail
Congress Session
Preventing heart failure: strategies for earlier diagnosis of ATTR cardiac amyloidosis
12 May 2024
thumbnail
Congress Presentation
Exploring the wealth of long-term data for ATTR-CM management​
31 August 2025
thumbnail
Congress Presentation
Summary.
29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources